{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:32:24Z","timestamp":1773102744688,"version":"3.50.1"},"reference-count":213,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1988,10,1]],"date-time":"1988-10-01T00:00:00Z","timestamp":591667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1988,10]]},"DOI":"10.1007\/bf03259892","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T11:27:49Z","timestamp":1354188469000},"page":"387-417","source":"Crossref","is-referenced-by-count":22,"title":["Non-Prescription Sympathomimetic Agents and Hypertension"],"prefix":"10.1007","volume":"3","author":[{"given":"S. S.","family":"Chua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. I.","family":"Benrimoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"issue":"1","key":"BF03259892_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0024-3205(67)90359-1","volume":"6","author":"AH Abdallah","year":"1967","unstructured":"Abdallah AH, Tye A, Lapidus JB, Patil PN. Effects of ephedrine isomers on myocardial catecholamines. Life Sciences 6(1): 39\u201343, 1967","journal-title":"Life Sciences"},{"key":"BF03259892_CR2","first-page":"549","volume":"6","author":"S Altschuler","year":"1982","unstructured":"Altschuler S, Conte A, Sebok M, Marlin RL, Winick C. Three controlled trials of weight loss with phenylpropanolamine. International Journal of Obesity 6: 549\u2013556, 1982","journal-title":"International Journal of Obesity"},{"key":"BF03259892_CR3","volume-title":"Australian pharmaceutical formulary and handbook","year":"1983","unstructured":"Anderson RA (Ed). Australian pharmaceutical formulary and handbook, 13th ed., Pharmaceutical Society of Australia, Canberra, 1983","edition":"13th"},{"key":"BF03259892_CR4","first-page":"651","volume":"139","author":"GD Appelt","year":"1985","unstructured":"Appelt GD. Safety of phenylpropanolamine. American Journal of Diseases of Children 139: 651\u2013652, 1985","journal-title":"American Journal of Diseases of Children"},{"issue":"7","key":"BF03259892_CR5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jama.1985.03350310059010","volume":"253","author":"P Aselton","year":"1985","unstructured":"Aselton P, Jick H, Hunter JB. Phenylpropanolamine exposure and subsequent hospitalisation. Journal of the American Medical Association 253(7): 977, 1985","journal-title":"Journal of the American Medical Association"},{"key":"BF03259892_CR6","volume-title":"Australian Health Survey 1983, Catalogue No. 4311.0","author":"Australian Bureau of Statistics, Commonwealth of Australia","year":"1986","unstructured":"Australian Bureau of Statistics, Commonwealth of Australia. Australian Health Survey 1983, Catalogue No. 4311.0, Australian Government Publishing Service, Canberra, 1986"},{"key":"BF03259892_CR7","volume-title":"Profile on fenoterol hydrobromide","author":"Australian National Drug Information Service, Commonwealth Department of Health","year":"1982","unstructured":"Australian National Drug Information Service, Commonwealth Department of Health. Profile on fenoterol hydrobromide, Australian Government Publishing Service, Canberra, 1982"},{"key":"BF03259892_CR8","volume-title":"Profile on salbutamol","author":"Australian National Drug Information Service, Commonwealth Department of Health","year":"1985","unstructured":"Australian National Drug Information Service, Commonwealth Department of Health. Profile on salbutamol, Australian Government Publishing Service, Canberra, 1985a"},{"key":"BF03259892_CR9","volume-title":"Profile on terbutaline","author":"Australian National Drug Information Service, Commonwealth Department of Health","year":"1985","unstructured":"Australian National Drug Information Service, Commonwealth Department of Health. Profile on terbutaline, Australian Government Publishing Service, Canberra, 1985b"},{"key":"BF03259892_CR10","first-page":"407","volume":"122","author":"DM Aviado Jr","year":"1958","unstructured":"Aviado Jr DM, Wnuck AL, De Beer EJ. Cardiovascular effects of sympathomimetic bronchodilators: epinephrine, ephedrine, pseudoephedrine, isoproterenol, methoxyphenamine and isoprophenamine. Journal of Pharmacology and Experimental Therapeutics 122: 407\u2013417, 1958","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"BF03259892_CR11","first-page":"62","volume":"109","author":"J Axelrod","year":"1953","unstructured":"Axelrod J. Studies on sympathomimetic amines I. the biotransformation and physiological disposition of 1-ephedrine and 1-norephedrine. Journal of Pharmacology and Experimental Therapeutics 109(1): 62\u201373, 1953","journal-title":"the biotransformation and physiological disposition of 1-ephedrine and 1-norephedrine. Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259892_CR12","first-page":"12","volume-title":"Side effects of drugs annual 7","author":"EA Babayan","year":"1983","unstructured":"Babayan EA, Astahova AV, Lepakhin VK, Lopatin AS. Central nervous system stimulants and anorectic agents. In Dukes (Ed.) Side effects of drugs annual 7, pp. 12\u201313, Excerpta Medica, Amsterdam, 1983"},{"issue":"4","key":"BF03259892_CR13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2125.1979.tb00971.x","volume":"7","author":"LR Bagg","year":"1979","unstructured":"Bagg LR, Empey DW, Hughes DTD, John GC, Letley E, et al. The determination of the optimal oral dose of pseudoephedrine for nasal decongestion using nasal histamine challenge and anterior rhinometry. British Journal of Clinical Pharmacology 7(4): 426P, 1979","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259892_CR14","first-page":"652","volume":"139","author":"JF Bale Jr","year":"1985","unstructured":"Bale Jr JF. Safety of phenylpropanolamine. American Journal of Diseases of Children 139: 652\u2013653, 1985","journal-title":"American Journal of Diseases of Children"},{"key":"BF03259892_CR15","first-page":"683","volume":"138","author":"JF Bale Jr","year":"1984","unstructured":"Bale Jr JF, Fountain MT, Shaddy R. Phenylpropanolamine-associated CNS complications in children and adolescents. American Journal of Diseases of Children 138: 683\u2013685, 1984","journal-title":"American Journal of Diseases of Children"},{"key":"BF03259892_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(79)90209-5","volume":"2","author":"WM Bennett","year":"1979","unstructured":"Bennett WM. Hazards of the appetite suppressant phenylpropanolamine. Lancet 2: 42\u201343, 1979","journal-title":"Lancet"},{"key":"BF03259892_CR17","first-page":"4","volume":"3","author":"CG Berbatis","year":"1979","unstructured":"Berbatis CG. Severe hypertension and phenylpropanolamine. Fremantle Hospital Drug Bulletin 3: 4, 1979","journal-title":"Fremantle Hospital Drug Bulletin"},{"key":"BF03259892_CR18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0196-0644(82)80130-3","volume":"11","author":"E Bernstein","year":"1982","unstructured":"Bernstein E, Diskant BM. Phenylpropanolamine: a potentially hazardous drug. Annals of Emergency Medicine 11: 311\u2013315, 1982","journal-title":"Annals of Emergency Medicine"},{"key":"BF03259892_CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.1987.03400020078035","volume":"258","author":"I Biaggioni","year":"1987","unstructured":"Biaggioni I, Onrot J, Stewart CK, Robertson D. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. Journal of the American Medical Association 258: 236\u2013239, 1987","journal-title":"Journal of the American Medical Association"},{"issue":"13","key":"BF03259892_CR20","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1001\/jama.1981.03310380050029","volume":"245","author":"A Blum","year":"1981","unstructured":"Blum A. Phenylpropanolamine: an over-the-counter amphetamine? Journal of the American Medical Association 245(13): 1346\u20131347, 1981","journal-title":"Journal of the American Medical Association"},{"key":"BF03259892_CR21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.1982.03320290010008","volume":"247","author":"A Blum","year":"1982","unstructured":"Blum A. Phenylpropanolamine. Journal of the American Medical Association 247: 460\u2013461, 1982","journal-title":"Journal of the American Medical Association"},{"key":"BF03259892_CR22","first-page":"16","volume":"25","author":"DA Brancato","year":"1981","unstructured":"Brancato DA, Cohen BI, Fow MI. Phenylpropanolamine weight control products. National Clearing House for Poisoning Control Centers Bulletin 25: 16\u201320, 1981","journal-title":"National Clearing House for Poisoning Control Centers Bulletin"},{"key":"BF03259892_CR23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/j.1552-4604.1981.tb05655.x","volume":"21","author":"TP Bright","year":"1981","unstructured":"Bright TP, Sandage Jr BW, Fletcher HP. Selected cardiac and metabolic responses to pseudoephedrine with exercise. Journal of Clinical Pharmacology 21: 488\u2013492, 1981","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"BF03259892_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.1978.tb01681.x","volume":"6","author":"MG Britton","year":"1978","unstructured":"Britton MG, Empey DW, John GC, McDonnell KA, Hughes DTD. Histamine challenge and anterior nasal rhinometry: their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever. British Journal of Clinical Pharmacology 6(1): 51\u201358, 1978","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259892_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1398-9995.1982.tb01879.x","volume":"37","author":"P Broms","year":"1982","unstructured":"Broms P, Malm L. Oral vasoconstrictors in perennial non-allergic rhinitis. Allergy 37: 67\u201374, 1982","journal-title":"Allergy"},{"key":"BF03259892_CR26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archopht.1980.01020030483009","volume":"98","author":"MM Brown","year":"1980","unstructured":"Brown MM, Brown GC, Spaeth GL. Lack of side-effects from topically administered 10% phenylephrine eyedrops (a controlled study). Archives of Ophthalmology 98: 487\u2013489, 1980","journal-title":"Archives of Ophthalmology"},{"key":"BF03259892_CR27","first-page":"176","volume":"75","author":"T Bryant-Stephens","year":"1986","unstructured":"Bryant-Stephens T. Cold remedies and heart disease. Medical Association of Georgia Journal 75: 176\u2013178, 1986","journal-title":"Medical Association of Georgia Journal"},{"key":"BF03259892_CR28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.1974.tb00209.x","volume":"1","author":"C Bye","year":"1974","unstructured":"Bye C, Dewsbury D, Peck AW. Effects on the human central nervous system of two isomers of ephedrine and triprolidine, and their interaction. British Journal of Clinical Pharmacology 1: 71\u201378, 1974","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259892_CR29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00616414","volume":"8","author":"C Bye","year":"1975","unstructured":"Bye C, Hill HM, Hughes DTD, Peck AW. A comparison of plasma levels of L(+)pseudoephedrine following different formulations, and their relation to cardiovascular and subjective effects in man. European Journal of Clinical Pharmacology 8: 47\u201353, 1975","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"3","key":"BF03259892_CR30","first-page":"206","volume":"26","author":"B Calesnick","year":"1982","unstructured":"Calesnick B. Nonprescription anorexiants. American Family Physician 26(3): 206\u2013208, 1982","journal-title":"American Family Physician"},{"key":"BF03259892_CR31","first-page":"81","volume-title":"Medicinal chemistry: part 1","author":"AF Casy","year":"1970","unstructured":"Casy AF. Stereochemistry and biological activity. In Burger (Ed.) Medicinal chemistry: part 1, pp. 81\u2013107, Wiley-Interscience, New York, 1970"},{"key":"BF03259892_CR32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00012995-198408000-00001","volume":"107","author":"S Chaplin","year":"1984","unstructured":"Chaplin S. Adverse reactions to sympathomimetics in cold remedies. Adverse Drug Reaction Bulletin 107: 396\u2013399, 1984","journal-title":"Adverse Drug Reaction Bulletin"},{"issue":"3","key":"BF03259892_CR33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3181\/00379727-22-99","volume":"22","author":"KK Chen","year":"1925","unstructured":"Chen KK. The effect of ephedrine on experimental shock and hemorrhage. Proceedings of the Society for Experimental Biology and Medicine 22(3): 203\u2013206, 1925a","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"issue":"7","key":"BF03259892_CR34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3181\/00379727-22-193","volume":"22","author":"KK Chen","year":"1925","unstructured":"Chen KK. The acute toxicity of ephedrine. Proceedings of the Society for Experimental Biology and Medicine 22(7): 404\u2013405, 1925b","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"issue":"8","key":"BF03259892_CR35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3181\/00379727-22-274","volume":"22","author":"KK Chen","year":"1925","unstructured":"Chen KK. The effect of repeated administration of ephedrine. Proceedings of the Society for Experimental Biology and Medicine 22(8): 568\u2013570, 1925c","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"BF03259892_CR36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/archinte.1927.00130030089007","volume":"39","author":"KK Chen","year":"1927","unstructured":"Chen KK. A comparative study of ephedrine, pseudoephedrine and \u03b2-phenyl-ethylamine. Archives of Internal Medicine 39: 404\u2013411, 1927","journal-title":"Archives of Internal Medicine"},{"key":"BF03259892_CR37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3565(25)03357-9","volume":"33","author":"KK Chen","year":"1928","unstructured":"Chen KK. A comparative study of synthetic and natural ephedrines. Journal of Pharmacology and Experimental Therapeutics 33: 237\u2013258, 1928","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"8","key":"BF03259892_CR38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jps.3080150804","volume":"15","author":"KK Chen","year":"1926","unstructured":"Chen KK, Kao CH. Ephedrine and pseudoephedrine, their isolation, constitution, isomerism, properties, derivatives and synthesis. Journal of the American Pharmaceutical Association 15(8): 625\u2013639, 1926","journal-title":"Journal of the American Pharmaceutical Association"},{"key":"BF03259892_CR39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3565(25)05503-X","volume":"28","author":"KK Chen","year":"1926","unstructured":"Chen KK, Meek WJ. Further studies on the effect of ephedrine on the circulation. Journal of Pharmacology and Experimental Therapeutics 28: 31\u201357, 1926a","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259892_CR40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-3565(25)05504-1","volume":"28","author":"KK Chen","year":"1926","unstructured":"Chen KK, Meek WJ. A comparative study of ephedrine, tyramine and epinephrine with special reference to the circulation. Journal of Pharmacology and Experimental Therapeutics 28: 59\u201376, 1926b","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"BF03259892_CR41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3181\/00379727-25-3744","volume":"25","author":"KK Chen","year":"1927","unstructured":"Chen KK, Poth EJ. The racial difference of the mydriatic action of ephedrines, cocaine, and euphthalmine. Proceedings of the Society for Experimental Biology and Medicines 25(2): 150\u2013151, 1927","journal-title":"Proceedings of the Society for Experimental Biology and Medicines"},{"key":"BF03259892_CR42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-3565(25)05630-7","volume":"24","author":"KK Chen","year":"1924","unstructured":"Chen KK, Schmidt CF. The action of ephedrine, the active principle of the Chinese drug Ma Huang. Journal of Pharmacology and Experimental Therapeutics 24: 339\u2013357, 1924","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259892_CR43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3181\/00379727-26-4296","volume":"26","author":"KK Chen","year":"1928","unstructured":"Chen KK, Wu CK, Henriksen E. Ephedrine homologs and isomers: relationship between their pharmacological action and their chemical constitution and stereoisomerism. Proceedings of the Society for Experimental Biology and Medicines 26: 348, 1928","journal-title":"Proceedings of the Society for Experimental Biology and Medicines"},{"issue":"3","key":"BF03259892_CR44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-3565(25)04091-1","volume":"36","author":"KK Chen","year":"1929","unstructured":"Chen KK, Wu CK, Henriksen E. Relationship between the pharmacological action and the chemical constitution and configuration of the optical isomers of ephedrine and related compounds. Journal of Pharmacology and Experimental Therapeutics 36(3): 363\u2013400, 1929","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259892_CR45","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/106002808301701008","volume":"17","author":"JE Clark","year":"1983","unstructured":"Clark JE, Simon WA. Cardiac arrhythmias after phenylpropanolamine. Drug Intelligence and Clinical Pharmacy 17: 737\u2013738, 1983","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259892_CR46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2165\/00003495-197815010-00005","volume":"15","author":"JE Crooks","year":"1978","unstructured":"Crooks JE, Nies AS. Drug interactions with antihypertensive drugs. Drugs 15: 72\u201379, 1978","journal-title":"Drugs"},{"key":"BF03259892_CR47","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/bmj.1.5641.404","volume":"1","author":"AF Cuthbert","year":"1969","unstructured":"Cuthbert AF, Greenberg MP, Morley SW. Cough and cold remedies: a potential danger to patients on monoamine oxidase inhibitors. British Medical Journal 1: 404\u2013406, 1969","journal-title":"British Medical Journal"},{"key":"BF03259892_CR48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(80)90913-7","volume":"1","author":"MF Cuthbert","year":"1980","unstructured":"Cuthbert MF. Anorectic and nasal decongestant preparations containing phenylpropanolamine. Lancet 1: 367, 1980","journal-title":"Lancet"},{"key":"BF03259892_CR49","volume-title":"Health care and life-style: a study of self-medication in Australia","author":"DN Darby","year":"1981","unstructured":"Darby DN, Glaser S, Wilkinson IF. Health care and life-style: a study of self-medication in Australia, New South Wales University Press Limited, New South Wales, 1981"},{"key":"BF03259892_CR50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00560458","volume":"14","author":"J Dickerson","year":"1978","unstructured":"Dickerson J, Perrier D, Mayersohn M, Bressler R. Dose tolerance and pharmacokinetic studies of L(+) pseudoephedrine capsules in man. European Journal of Clinical Pharmacology 14: 253\u2013259, 1978","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259892_CR51","first-page":"23","volume":"7","author":"SB Dimson","year":"1934","unstructured":"Dimson SB. The pressor actions of ephedrine and pseudoephedrine in man. Quarterly Journal of Pharmacy and Pharmacology 7: 23\u201331, 1934","journal-title":"Quarterly Journal of Pharmacy and Pharmacology"},{"issue":"3","key":"BF03259892_CR52","first-page":"65","volume":"65","author":"DE Dowd","year":"1972","unstructured":"Dowd DE. Phenylephrine in aerosols: absence of effect on pulmonary artery pressure. Journal of the Irish Medical Association 65(3): 65\u201366, 1972","journal-title":"Journal of the Irish Medical Association"},{"issue":"1","key":"BF03259892_CR53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3181\/00379727-25-3677","volume":"25","author":"CA Dragstedt","year":"1927","unstructured":"Dragstedt CA, Wightmen AH. Observations on hemodynamic effect of epinephrine in unanaesthetized dog. Proceedings of the Society for Experimental Biology and Medicine 25(1): 22\u201324, 1927","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"BF03259892_CR54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2125.1978.tb04588.x","volume":"6","author":"CDM Drew","year":"1978","unstructured":"Drew CDM, Knight GT, Hughes DTD, Bush M. Comparison of the effects of D-(\u2212)-ephedrine and L-(+)-pseudoephedrine on the cardiovascular and respiratory systems in man. British Journal of Clinical Pharmacology 6: 221\u2013225, 1978","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259892_CR55","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/archopht.1983.01040020905014","volume":"101","author":"RM Duffin","year":"1983","unstructured":"Duffin RM, Pettit TH, Straatsma BR. 2.5% v 10% phenylephrine in maintaining mydriasis during cataract surgery. Archives of Ophthalmology 101: 1903\u20131906, 1983","journal-title":"Archives of Ophthalmology"},{"issue":"16","key":"BF03259892_CR56","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM196904172801608","volume":"280","author":"WFC Duvernoy","year":"1969","unstructured":"Duvernoy WFC. Positive phentolamine test in hypertension induced by a nasal decongestant. New England Journal of Medicine 280(16): 877, 1969","journal-title":"New England Journal of Medicine"},{"key":"BF03259892_CR57","first-page":"2","volume":"1","author":"Editorial","year":"1974","unstructured":"Editorial. Babies\u2019 blood pressure raised by eye drops. British Medical Journal 1: 2\u20133, 1974","journal-title":"British Medical Journal"},{"key":"BF03259892_CR58","first-page":"839","volume":"1","author":"Editorial","year":"1982","unstructured":"Editorial. Phenylpropanolamine over the counter. Lancet 1: 839, 1982","journal-title":"Lancet"},{"key":"BF03259892_CR59","first-page":"81","volume":"25","author":"BR Ekins","year":"1983","unstructured":"Ekins BR, Spoerke Jr DG. An estimation of the toxicity of non-prescription diet aids from seventy exposure cases. Veterinary and Human Toxicology 25: 81\u201385, 1983","journal-title":"Veterinary and Human Toxicology"},{"key":"BF03259892_CR60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.2.5544.75","volume":"2","author":"J Elis","year":"1967","unstructured":"Elis J, Laurence DR, Mattie H, Prichard BNC. Modifications by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure. British Medical Journal 2: 75\u201378, 1967","journal-title":"British Medical Journal"},{"key":"BF03259892_CR61","first-page":"715","volume":"1","author":"CF Elliott","year":"1981","unstructured":"Elliott CF, Whyte JC. Phenylpropanolamine and hypertension. Medical Journal of Australia 1: 715, 1981","journal-title":"Medical Journal of Australia"},{"key":"BF03259892_CR62","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2125.1984.tb05026.x","volume":"18","author":"DW Empey","year":"1984","unstructured":"Empey DW, Fronsolono MF, Hughes DTD, Perkins JG. Comparison of pseudoephedrine and triprolidine, alone and in combination in preventing nasal congestion in subjects with allergic rhinitis using nasal histamine challenge. British Journal of Clinical Pharmacology 18: 86\u201389, 1984","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259892_CR63","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2125.1980.tb01061.x","volume":"9","author":"DW Empey","year":"1980","unstructured":"Empey DW, Young GA, Letley E, John GC, Smith P, et al. Dose-response study of the nasal decongestant and cardiovascular effects of pseudoephedrine. British Journal of Clinical Pharmacology 9: 351\u2013358, 1980","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"6","key":"BF03259892_CR64","first-page":"735","volume":"13","author":"DL Epstein","year":"1981","unstructured":"Epstein DL, Murphy E. Effect of combined 1% cyclopentolate-10% phenylephrine eyedrops on systemic blood pressure of glaucoma patients. Annals of Ophthalmology 13(6): 735\u2013736, 1981","journal-title":"Annals of Ophthalmology"},{"key":"BF03259892_CR65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.35.3.405","volume":"35","author":"RJ Fallis","year":"1985","unstructured":"Fallis RJ, Fisher M. Cerebral vasculitis and hemorrhage associated with phenylpropanolamine. Neurology 35: 405\u2013407, 1985","journal-title":"Neurology"},{"key":"BF03259892_CR66","first-page":"351","volume":"62","author":"HV Feehan","year":"1981","unstructured":"Feehan HV. Medication patterns: lessons to be learned. Australian Journal of Pharmacy 62: 351\u2013355, 1981","journal-title":"Australian Journal of Pharmacy"},{"issue":"12","key":"BF03259892_CR67","first-page":"469","volume":"75","author":"M Fergus","year":"1982","unstructured":"Fergus M, McNicholl B. Drug-induced hypertension and cerebral irritation in an infant. Irish Medical Journal 75(12): 469\u2013470, 1982","journal-title":"Irish Medical Journal"},{"issue":"1","key":"BF03259892_CR68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5694\/j.1326-5377.1986.tb113624.x","volume":"1445","author":"SA Finau","year":"1986","unstructured":"Finau SA, Prior IAM, Salmond CE. Hypertension among urban and rural Tongans. Medical Journal of Australia 1445(1): 16\u201320, 1986","journal-title":"Medical Journal of Australia"},{"issue":"8","key":"BF03259892_CR69","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/archopht.1986.01050200098059","volume":"104","author":"JC Folk","year":"1986","unstructured":"Folk JC, Kumar V, Piper JG, Barcellos WA, Schoenwald RD, et al. Aqueous vs viscous phenylephrine II. mydriatic effects. Archives of Ophthalmology 104(8): 1192\u20131193, 1986","journal-title":"mydriatic effects. Archives of Ophthalmology"},{"key":"BF03259892_CR70","unstructured":"Food and Drug Administration. Federal Register: establishment of a monograph for OTC cold, cough, allergy, bronchodilator and antiasthmatic products, Part II, Vol. 41 (176), Department of Health, Education and Welfare, United States, 1976"},{"key":"BF03259892_CR71","unstructured":"Food and Drug Administration. Federal Register: tentative final monograph for over-the-counter nasal decongestant drug products, Part IX, Vol. 50 (10), Department of Health and Human Service, United States, 1985"},{"key":"BF03259892_CR72","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0002-9394(85)90371-X","volume":"99","author":"FT Fraunfelder","year":"1985","unstructured":"Fraunfelder FT, Meyer SM. Possible cardiovascular effects secondary to topical ophthalmic 2.5% phenylephrine. American Journal of Ophthalmology 99: 362\u2013363, 1985","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259892_CR73","first-page":"209","volume":"28","author":"FT Fraunfelder","year":"1987","unstructured":"Fraunfelder FT, Meyer SM. Systemic reactions to ophthalmic drug preparations. Current Therapeutics 28: 209\u2013222, 1987","journal-title":"Current Therapeutics"},{"issue":"4","key":"BF03259892_CR74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9394(14)75239-0","volume":"85","author":"FT Fraunfelder","year":"1978","unstructured":"Fraunfelder FT, Scafidi AF. Possible adverse effects from topical ocular 10% phenylephrine. American Journal of Ophthalmology 85(4): 447\u2013453, 1978","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259892_CR75","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5694\/j.1326-5377.1978.tb131671.x","volume":"2","author":"DB Frewin","year":"1978","unstructured":"Frewin DB, Leonello PP, Frewin ME. Hypertension after ingestion of Trimolets. Medical Journal of Australia 2: 497\u2013498, 1978","journal-title":"Medical Journal of Australia"},{"key":"BF03259892_CR76","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5694\/j.1326-5377.1983.tb142095.x","volume":"2","author":"DB Frewin","year":"1983","unstructured":"Frewin DB. Phenylpropanolamine: how safe is it? Medical Journal of Australia 2: 54\u201355, 1983","journal-title":"Medical Journal of Australia"},{"key":"BF03259892_CR77","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0140-6736(72)91893-4","volume":"2","author":"GJ Gibson","year":"1972","unstructured":"Gibson GJ, Warrell DA. Hypertensive crisis and phenylpropanolamine. Lancet 2: 492, 1972","journal-title":"Lancet"},{"key":"BF03259892_CR78","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0002-8703(87)90293-6","volume":"113","author":"RG Gibson","year":"1987","unstructured":"Gibson RG, Oliver JA, Leak D. Nifedipine therapy of phenylpropanolamine-induced hypertension. American Heart Journal 113 (2 Pt. 1): 406\u2013407, 1987","journal-title":"American Heart Journal"},{"issue":"2","key":"BF03259892_CR79","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/clpt.1986.153","volume":"40","author":"RP Goodman","year":"1986","unstructured":"Goodman RP, Wright Jr JT, Barlascini CO, McKenney JM, Lambert CM. The effect of phenylpropanolamine on ambulatory blood pressure. Clinical Pharmacology and Therapeutics 40(2): 144\u2013147, 1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"BF03259892_CR80","first-page":"252","volume":"11","author":"GK Greening","year":"1969","unstructured":"Greening GK. The effect of an antihistamine-pseudoephedrine drug on the blood pressure of moderate hypertensives. Current Therapeutic Research 11(5): 252\u2013255, 1969","journal-title":"Current Therapeutic Research"},{"key":"BF03259892_CR81","first-page":"585","volume":"230","author":"J Greenwood","year":"1983","unstructured":"Greenwood J. The case against phenylpropanolamine. Pharmaceutical Journal 230: 585\u2013586, 1983","journal-title":"Pharmaceutical Journal"},{"issue":"4","key":"BF03259892_CR82","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/cpt196674510","volume":"7","author":"OD Gulati","year":"1966","unstructured":"Gulati OD, Dave BT, Gokhale SD, Shah KM. Antagonism of adrenergic neuron blockade in hypertensive subjects. Clinical Pharmacology and Therapeutics 7(4): 510\u2013514, 1966","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259892_CR83","volume-title":"Textbook of medical physiology","year":"1986","unstructured":"Guyton AC (Ed.). Textbook of medical physiology, 7th ed., Igaku-Shoin\/Saunders\u2019 International, Japan, 1986","edition":"7th"},{"issue":"5","key":"BF03259892_CR84","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0002-9394(70)90490-3","volume":"70","author":"NJ Haddad","year":"1970","unstructured":"Haddad NJ, Moyer NJ, Riley FC. Mydriatic effect of phenylephrine hydrochloride. American Journal of Ophthalmology 70(5): 729\u2013733, 1970","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"BF03259892_CR85","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1532-5415.1981.tb01973.x","volume":"29","author":"WE Hale","year":"1981","unstructured":"Hale WE, Marks RG, Stewart RB. Screening for hypertension in an elderly population: report from the Dunedin Program. Journal of the American Geriatrics Society 29(3): 123\u2013125, 1981","journal-title":"Journal of the American Geriatrics Society"},{"key":"BF03259892_CR86","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1021\/cr60034a002","volume":"9","author":"WH Hartung","year":"1932","unstructured":"Hartung WH. Epinephrine and related compounds: influence of structure on physiological activity. Chemical Reviews 9: 389\u2013465, 1932","journal-title":"Chemical Reviews"},{"key":"BF03259892_CR87","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archopht.1936.00840230119009","volume":"16","author":"P Heath","year":"1936","unstructured":"Heath P. Neosynephrin hydrochloride: some uses and effects in ophthalmology. Archives of Ophthalmology 16: 839\u2013846, 1936","journal-title":"Archives of Ophthalmology"},{"key":"BF03259892_CR88","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/archopht.1949.00900040177003","volume":"41","author":"P Heath","year":"1949","unstructured":"Heath P, Geiter CW. Use of phenylephrine hydrochloride (Neo-synephrine hydrochloride) in ophthalmology. Archives of Ophthalmology 41: 172\u2013177, 1949","journal-title":"Archives of Ophthalmology"},{"key":"BF03259892_CR89","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(80)90490-0","volume":"1","author":"JD Horowitz","year":"1980","unstructured":"Horowitz JD, Lang WJ, Howes LG, Fennessy MR, Christophidis N, et al. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations. Lancet 1: 60\u201361, 1980","journal-title":"Lancet"},{"key":"BF03259892_CR90","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5694\/j.1326-5377.1979.tb128964.x","volume":"1","author":"JD Horowitz","year":"1979","unstructured":"Horowitz JD, McNell JJ, Sweet B, Mendelsohn FAO, Louis WJ. Hypertension and postural hypotension induced by phenylpropanolamine (Trimolets). Medical Journal of Australia 1: 175\u2013176, 1979","journal-title":"Medical Journal of Australia"},{"key":"BF03259892_CR91","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1152\/ajplegacy.1954.178.3.387","volume":"178","author":"SM Horvath","year":"1954","unstructured":"Horvath SM, Knapp DW. Hemodynamic effects of Neosynephrine. American Journal of Physiology 178: 387\u2013391, 1954","journal-title":"American Journal of Physiology"},{"issue":"7","key":"BF03259892_CR92","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3181\/00379727-24-3524","volume":"24","author":"HJ Howard","year":"1927","unstructured":"Howard HJ, Lee TP. The effect of instillations of ephedrine solution upon the eye. Proceedings of the Society for Experimental Biology and Medicine 24(7): 700\u2013702, 1927","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"issue":"1","key":"BF03259892_CR93","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-3476(83)80314-X","volume":"102","author":"DL Howrie","year":"1983","unstructured":"Howrie DL, Wolfson JH. Phenylpropanolamine-induced hypertensive seizures. Journal of Pediatrics 102(1): 143\u2013145, 1983","journal-title":"Journal of Pediatrics"},{"key":"BF03259892_CR94","first-page":"315","volume":"8","author":"DTD Hughes","year":"1983","unstructured":"Hughes DTD, Empey DW, Land M. Effects of pseudoephedrine in man. Journal of Clinical and Hospital Pharmacy 8: 315\u2013321, 1983","journal-title":"Journal of Clinical and Hospital Pharmacy"},{"key":"BF03259892_CR95","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/bmj.1.5647.846","volume":"1","author":"PM Humberstone","year":"1969","unstructured":"Humberstone PM. Hypertension from cold remedies. British Medical Journal 1: 846, 1969","journal-title":"British Medical Journal"},{"key":"BF03259892_CR96","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.1985.03350350103032","volume":"253","author":"JS Hyams","year":"1985","unstructured":"Hyams JS, Leichtner AM, Breiner RG, Hill DW, McComb RB, et al. Pseudopheochromocytoma and cardiac arrest associated with phenylpropanolamine. Journal of the American Medical Association 253: 1609\u20131610, 1985","journal-title":"Journal of the American Medical Association"},{"issue":"5","key":"BF03259892_CR97","first-page":"382","volume":"57","author":"BJ Jennings","year":"1986","unstructured":"Jennings BJ, Sullivan DE. The effects of topical 2.5% phenylephrine and 1% tropicamide on systemic blood pressure and pulse. Journal of the American Optometric Association 57(5): 382\u2013389, 1986","journal-title":"Journal of the American Optometric Association"},{"key":"BF03259892_CR98","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(84)92354-7","volume":"1","author":"H Jick","year":"1984","unstructured":"Jick H, Aselton P, Hunter JR. Phenylpropanolamine and cerebral haemorrhage. Lancet 1: 1017, 1984","journal-title":"Lancet"},{"key":"BF03259892_CR99","first-page":"145","volume":"61","author":"SG Kailis","year":"1980","unstructured":"Kailis SG. OTC preparations containing phenylpropanolamine: should their sale be restricted? Australia Journal of Pharmacy 61: 145\u2013149, 1980","journal-title":"Australia Journal of Pharmacy"},{"key":"BF03259892_CR100","first-page":"1","volume-title":"Clinical hypertension","author":"NM Kaplan","year":"1973","unstructured":"Kaplan NM. The approach to the hypertensive patient. In Lauler et al. (Eds) Clinical hypertension, pp. 1\u201333, Medcom Press, New York, 1973"},{"issue":"3","key":"BF03259892_CR101","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1212\/WNL.37.3.399","volume":"37","author":"CS Kase","year":"1987","unstructured":"Kase CS, Foster TE, Read JE, Spatz EL, Girgis GN. Intracerebral hemorrhage and phenylpropanolamine use. Neurology 37(3): 399\u2013404, 1987","journal-title":"Neurology"},{"key":"BF03259892_CR102","volume-title":"Drug facts and comparison","year":"1984","unstructured":"Kastrup EK, Olin BR, Boyd JR (Eds). Drug facts and comparison, J.B. Lippincott Co., St. Louis, 1984"},{"key":"BF03259892_CR103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI101270","volume":"21","author":"A Keys","year":"1942","unstructured":"Keys A, Violante A. The cardio-circulatory effects in man of Neosynephrin. Journal of Clinical Investigation 21: 1\u201312, 1942","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"BF03259892_CR104","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.STR.16.3.510","volume":"16","author":"DG Kikta","year":"1985","unstructured":"Kikta DG, Devereaux MW, Chandar K. Intracranial hemorrhages due to phenylpropanolamine. Stroke 16(3): 510\u2013512, 1985","journal-title":"Stroke"},{"key":"BF03259892_CR105","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0002-9394(14)78119-X","volume":"85","author":"JM Kim","year":"1978","unstructured":"Kim JM, Stevenson CE, Mathewson HS. Hypertensive reactions to phenylephrine eyedrops in patients with sympathetic denervation. American Journal of Ophthalmology 85: 862\u2013868, 1978","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259892_CR106","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5694\/j.1326-5377.1979.tb127123.x","volume":"1","author":"J King","year":"1979","unstructured":"King J. Hypertension and cerebral haemorrhage after Trimolets ingestion. Medical Journal of Australia 1: 258, 1979","journal-title":"Medical Journal of Australia"},{"key":"BF03259892_CR107","first-page":"131","volume":"7","author":"V Kumar","year":"1985","unstructured":"Kumar V, Packer AJ, Choi WW. Hypertension following phenylephrine 2.5% ophthalmic drops. Glaucoma 7: 131\u2013132, 1985a","journal-title":"Glaucoma"},{"issue":"8","key":"BF03259892_CR108","first-page":"1189","volume":"104","author":"V Kumar","year":"1986","unstructured":"Kumar V, Schoenwald RD, Barcellos WA, Chien DS, Folk JC, et al. Aqueous vs viscous phenylephrine I. systemic absorption and cardiovascular effects. Archives of Ophthalmology 104(8): 1189\u20131191, 1986","journal-title":"systemic absorption and cardiovascular effects. Archives of Ophthalmology"},{"issue":"2","key":"BF03259892_CR109","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0002-9394(85)90229-6","volume":"99","author":"V Kumar","year":"1985","unstructured":"Kumar V, Schoenwald RD, Chien DS, Packer AJ, Choi WW. Systemic absorption and cardiovascular effects of phenylephrine eyedrops. American Journal of Ophthalmology 99(2): 180\u2013184, 1985b","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259892_CR110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00545963","volume":"23","author":"LA Laitinen","year":"1982","unstructured":"Laitinen LA, Empey DW, Bye C, Britton MG, McDonnell K, et al. A comparison of the bronchodilator action of pseudoephedrine and ephedrine in patients with reversible airway obstruction. European Journal of Clinical Pharmacology 23: 107\u2013109, 1982","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259892_CR111","volume-title":"Prescribing for the elderly","year":"1982","unstructured":"Lamy PP (Ed). Prescribing for the elderly, John Wright PSG Inc., Massachusetts, 1982"},{"issue":"1","key":"BF03259892_CR112","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9394(66)90752-5","volume":"61","author":"RK Lansche","year":"1966","unstructured":"Lansche RK. Systemic reactions to topical epinephrine and phenylephrine. American Journal of Ophthalmology 61(1): 95\u201398, 1966","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259892_CR113","first-page":"546","volume":"28","author":"WL Larson","year":"1986","unstructured":"Larson WL, Rogers A. Overdosage of phenylpropanolamine: experience of the Hennepin Regional Poison Center. Veterinary and Human Toxicology 28: 546\u2013548, 1986","journal-title":"Veterinary and Human Toxicology"},{"key":"BF03259892_CR114","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1001\/jama.1985.03350410037006","volume":"253","author":"L Lasagna","year":"1985","unstructured":"Lasagna L. Phenylpropanolamine and blood pressure. Journal of the American Medical Association 253: 2491\u20132492, 1985","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"BF03259892_CR115","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0140-6736(79)91791-4","volume":"1","author":"KY Lee","year":"1979","unstructured":"Lee KY, Vandongen R, Beilin LJ. Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin. Lancet 1(2): 1110\u20131111, 1979","journal-title":"Lancet"},{"key":"BF03259892_CR116","first-page":"1","volume-title":"Side effects of drugs annual 10","author":"VK Lepakhin","year":"1986","unstructured":"Lepakhin VK, Babayan EA, Astahova AV, Rudenko GM. Central nervous system stimulants and anorectic agents. In Dukes (Ed.) Side effects of drugs annual 10, pp. 1\u201313, Elsevier Science Publishers, Amsterdam, 1986"},{"key":"BF03259892_CR117","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/j.1552-4604.1987.tb03089.x","volume":"27","author":"I Liebson","year":"1987","unstructured":"Liebson I, Bigelow G, Griffiths RR, Funderburk FR. Phenylpropanolamine: effects on subjective and cardiovascular variables at recommended over-the-counter dose levels. Journal of Cliinical Pharmacology 27: 685\u2013693, 1987","journal-title":"Journal of Cliinical Pharmacology"},{"issue":"1","key":"BF03259892_CR118","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jps.2600740107","volume":"74","author":"C Lin","year":"1985","unstructured":"Lin C, Kim H, Lim J, Digiore C, Symchowicz S, et al. Steady-state bioavailability of dexbrompheniramine and pseudoephedrine from a repeat-action combination tablet. Journal of Pharmaceutical Sciences 74(1): 25\u201328, 1985","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"BF03259892_CR119","volume-title":"The poisons regulations, S.R. Hampson","author":"PG Livingstone","year":"1986","unstructured":"Livingstone PG, Director-General of Health and Medical Services for the State of Queensland. The poisons regulations, S.R. Hampson, Government Printer, Queensland, 1986"},{"key":"BF03259892_CR120","first-page":"143","volume":"196","author":"PH Livingston","year":"1966","unstructured":"Livingston PH. Transient hypertension and phenylpropanolamine. Journal of the American Medical Association 196: 143, 1966","journal-title":"Journal of the American Medical Association"},{"key":"BF03259892_CR121","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/bmj.289.6445.591","volume":"289","author":"AW Logie","year":"1984","unstructured":"Logie AW, Scott CM. Fatal overdosage of phenylpropanolamine. British Medical Journal 289: 591, 1984","journal-title":"British Medical Journal"},{"key":"BF03259892_CR122","first-page":"387","volume":"10","author":"KLK Ludwikowski","year":"1984","unstructured":"Ludwikowski KLK. PPA: an innocent over-the-counter drug? Pediatric Nursing 10: 387\u2013390, 1984","journal-title":"Pediatric Nursing"},{"key":"BF03259892_CR123","doi-asserted-by":"crossref","first-page":"246","DOI":"10.7326\/0003-4819-85-2-246","volume":"85","author":"W Luqman","year":"1976","unstructured":"Luqman W, Danowski TS. The use of khat (Catha edulis) in Yemen social and medical observations. Annals of Internal Medicine 85: 246\u2013249, 1976","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"BF03259892_CR124","first-page":"330","volume":"52","author":"CK Maitai","year":"1975","unstructured":"Maitai CK. D-norpseudoephedrine as an anti-asthmatic: comparison with L-ephedrine, D-pseudoephedrine. East African Medical Journal 52(6): 330\u2013332, 1975","journal-title":"East African Medical Journal"},{"issue":"2","key":"BF03259892_CR125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0735-6757(86)90159-2","volume":"4","author":"PJ Mariani","year":"1986","unstructured":"Mariani PJ. Pseudoephedrine-induced hypertensive emergency: treatment with labetalol. American Journal of Emergency Medicine 4(2): 141\u2013142, 1986","journal-title":"American Journal of Emergency Medicine"},{"key":"BF03259892_CR126","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/bmj.1.5647.845-b","volume":"1","author":"AMS Mason","year":"1969","unstructured":"Mason AMS, Buckle RM. \u2018Cold\u2019 cures and monoamine-oxidase inhibitors. British Medical Journal 1: 845\u2013846, 1969","journal-title":"British Medical Journal"},{"key":"BF03259892_CR127","volume-title":"American Hospital Formulary Service (AHFS)","year":"1986","unstructured":"McEvoy GK (Ed.). American Hospital Formulary Service (AHFS), American Society of Hospital Pharmacists, Inc., USA, 1986"},{"key":"BF03259892_CR128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5694\/j.1326-5377.1983.tb142106.x","volume":"2","author":"J McEwen","year":"1983","unstructured":"McEwen J. Phenylpropanolamine-associated hypertension after the use of \u2018over-the-counter\u2019 appetite-suppressant products. Medical Journal of Australia 2: 71\u201373, 1983","journal-title":"Medical Journal of Australia"},{"key":"BF03259892_CR129","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bmj.2.6030.283-a","volume":"2","author":"EH McLaren","year":"1976","unstructured":"McLaren EH. Severe hypertension produced by interaction of phenylpropanolamine with methyldopa and oxprenolol. British Medical Journal 2: 283\u2013284, 1976","journal-title":"British Medical Journal"},{"key":"BF03259892_CR130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1288\/00005537-196101000-00007","volume":"71","author":"JW McLaurin","year":"1961","unstructured":"McLaurin JW, Shipman WF, Rosedale R. Oral decongestants, a double blind comparison study of the effectiveness of four sympthomimetic drugs: objective and subjective. Laryngoscope 71: 54\u201367, 1961","journal-title":"Laryngoscope"},{"key":"BF03259892_CR131","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archopht.1956.00930040184003","volume":"56","author":"WU McReynolds","year":"1956","unstructured":"McReynolds WU, Havener WH, Henderson JW. Hazards of the use of sympathomimetic drugs in ophthalmology. Archives of Ophthalmology 56: 176\u2013179, 1956","journal-title":"Archives of Ophthalmology"},{"key":"BF03259892_CR132","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/00007611-198407000-00045","volume":"77","author":"B Mesnard","year":"1984","unstructured":"Mesnard B, Ginn DR. Excessive phenylpropanolamine ingestion followed by subarachnoid hemorrhage. Southern Medical Journal 77: 939, 1984","journal-title":"Southern Medical Journal"},{"issue":"6","key":"BF03259892_CR133","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archinte.1979.03630430058019","volume":"139","author":"FH Messerli","year":"1979","unstructured":"Messerli FH, Frohlich ED. High blood pressure \u2014 a side effect of drugs, poisons, and food. Archives of Internal Medicine 139(6): 682\u2013687, 1979","journal-title":"Archives of Internal Medicine"},{"issue":"11","key":"BF03259892_CR134","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0161-6420(80)35108-7","volume":"87","author":"SM Meyer","year":"1980","unstructured":"Meyer SM, Fraunfelder FT. Phenylephrine hydrochloride. Ophthalmology 87(11): 1177\u20131180, 1980","journal-title":"Ophthalmology"},{"key":"BF03259892_CR135","volume-title":"Review of medical pharmacology","author":"FH Meyers","year":"1976","unstructured":"Meyers FH, Jawetz E, Goldfien A. Review of medical pharmacology. 5th ed., Lange Medical Publications, California, 1976","edition":"5th"},{"key":"BF03259892_CR136","first-page":"291","volume":"13","author":"SA Miller","year":"1973","unstructured":"Miller SA, Mieler WF. Systemic reaction to subconjunctival phenylephrine. Canadian Journal of Ophthalmology 13: 291\u2013293, 1973","journal-title":"Canadian Journal of Ophthalmology"},{"key":"BF03259892_CR137","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/bmj.4.5731.347","volume":"4","author":"JR Misage","year":"1970","unstructured":"Misage JR, McDonald RH. Antagonism of hypotensive action of bethanidine by \u2018common cold\u2019 remedy. British Medical Journal 4: 347, 1970","journal-title":"British Medical Journal"},{"issue":"1","key":"BF03259892_CR138","first-page":"47","volume":"10","author":"CA Mitchell","year":"1968","unstructured":"Mitchell CA. Possible cardiovascular effect of phenylpropanolamine and belladonna alkaloids. Current Therapeutic Research 10(1): 47\u201353, 1968","journal-title":"Current Therapeutic Research"},{"key":"BF03259892_CR139","first-page":"3","volume-title":"Phenylpropanolamine: risks, benefits and controversies","author":"JP Morgan","year":"1985","unstructured":"Morgan JP. Over-the-counter medication: availability and issues. In Morgan et al. (Eds) Phenylpropanolamine: risks, benefits and controversies, pp. 3\u201310, Praeger Publishers, New York, 1985a"},{"key":"BF03259892_CR140","first-page":"180","volume-title":"Phenylpropanolamine: risks, benefits and controversies","author":"JP Morgan","year":"1985","unstructured":"Morgan JP. Norephedrine and norpseudoephedrine: pharmacologically and clinically distinct isomers of phenylpropanolamine. In Morgan et al. (Eds) Phenylpropanolamine: risks, benefits and controversies, pp. 180\u2013194, Praeger Publications, New York, 1985b"},{"key":"BF03259892_CR141","volume-title":"Phenylpropanolamine: a critical analysis of reported adverse reactions and overdosage","author":"JP Morgan","year":"1986","unstructured":"Morgan JP. Phenylpropanolamine: a critical analysis of reported adverse reactions and overdosage. Jack K, Burgess, Inc., Fort Lee, New Jersey, 1986"},{"issue":"1","key":"BF03259892_CR142","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/clpt.1986.17","volume":"39","author":"JP Morgan","year":"1986","unstructured":"Morgan JP, Puder KS, Wang BW. Phenylpropanolamine and blood pressure. Clinical Pharmacology and Therapeutics 39(1): 102\u2013103, 1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"BF03259892_CR143","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/02791072.1987.10472376","volume":"19","author":"JP Morgan","year":"1987","unstructured":"Morgan JP, Wesson DR, Puder KS, Smith DE. Duplicitous drugs: the history and recent status of look-alike drugs. Journal of Psychoactive Drugs 19(1): 21\u201331, 1987","journal-title":"Journal of Psychoactive Drugs"},{"issue":"1","key":"BF03259892_CR144","first-page":"13","volume":"5","author":"TO Morgan","year":"1981","unstructured":"Morgan TO. Diet and salt. Australian Prescriber 5(1): 13\u201314, 1981","journal-title":"Australian Prescriber"},{"issue":"1","key":"BF03259892_CR145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.STR.15.1.119","volume":"15","author":"SM Mueller","year":"1984","unstructured":"Mueller SM, Muller J, Asdell SM. Cerebral hemorrhage associated with phenylpropanolamine in combination with caffeine. Stroke 15(1): 119\u2013123, 1984","journal-title":"Stroke"},{"issue":"11","key":"BF03259892_CR146","first-page":"653","volume":"308","author":"SM Mueller","year":"1983","unstructured":"Mueller SM. Phenylpropanolamine, a nonprescription drug with potentially fatal side effects. New England Journal of Medicine 308(11): 653, 1983a","journal-title":"New England Journal of Medicine"},{"key":"BF03259892_CR147","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.33.5.650","volume":"33","author":"SM Mueller","year":"1983","unstructured":"Mueller SM. Neurologic complications of phenylpropanolamine use. Neurology 33: 650\u2013652, 1983b","journal-title":"Neurology"},{"key":"BF03259892_CR148","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/clpt.1984.139","volume":"36","author":"MG Myers","year":"1984","unstructured":"Myers MG. Beta adrenoceptor antagonism and pressor response to phenylephrine. Clinical Pharmacology and Therapeutics 36: 57\u201363, 1984","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259892_CR149","first-page":"365","volume":"127","author":"MG Myers","year":"1982","unstructured":"Myers MG, Lazzetta JJ. Intranasally administered phenylephrine on blood pressure. Canadian Medical Association Journal 127: 365\u2013368, 1982","journal-title":"Canadian Medical Association Journal"},{"key":"BF03259892_CR150","volume-title":"Standard for the uniform scheduling of drugs and poisons","author":"National HealthMedical Research Council, Commonwealth Department of Health","year":"1986","unstructured":"National Health and Medical Research Council, Commonwealth Department of Health. Standard for the uniform scheduling of drugs and poisons, Australian Government Publishing Service, Canberra, 1986"},{"key":"BF03259892_CR151","unstructured":"National Heart Foundation of Australia. Risk factor prevalence study report, No. 2, 1983"},{"key":"BF03259892_CR152","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(82)92538-7","volume":"1","author":"RE Noble","year":"1982","unstructured":"Noble RE. Phenylpropanolamine and blood pressure. Lancet 1: 1419, 1982","journal-title":"Lancet"},{"key":"BF03259892_CR153","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/106002808802200403","volume":"22","author":"R Noble","year":"1988","unstructured":"Noble R. A controlled clinical trial of the cardiovascular and psychological effects of phenylpropanolamine and caffeine. Drug Intelligence and Clinical Pharmacy 22: 296\u2013299, 1988","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259892_CR154","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.1965.03090170150037","volume":"194","author":"S Ostern","year":"1965","unstructured":"Ostern S, Dodson WH. Hypertension following Ornade ingestion. Journal of the American Medical Association 194: 472, 1965","journal-title":"Journal of the American Medical Association"},{"key":"BF03259892_CR155","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/0003-4819-95-6-711","volume":"95","author":"JG Ouslander","year":"1981","unstructured":"Ouslander JG. Drug therapy in the elderly. Annals of Internal Medicine 95: 711\u2013722, 1981","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"BF03259892_CR156","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-3565(25)27520-6","volume":"155","author":"PN Patil","year":"1967","unstructured":"Patil PN, Lapidus JB, Campbell D, Tye A. Steric aspects of adrenergic drugs II: effects of DL isomers and desoxy derivatives on the reserpine-pretreated vas deferens. Journal of Pharmacology and Experimental Therapeutics 155(1): 13\u201323, 1967a","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"BF03259892_CR157","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jps.2600560233","volume":"56","author":"PN Patil","year":"1967","unstructured":"Patil PN, Lapidus JB, Molinari S, Tye A. Steric aspects of adrenergic drugs IV: antagonism of norepinephrine effects by ephedrine isomers on the isolated rabbit ileum. Journal of Pharmaceutical Sciences 56(2): 287\u2013288, 1967b","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"9","key":"BF03259892_CR158","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/jps.2600590902","volume":"59","author":"PN Patil","year":"1970","unstructured":"Patil PN, Lapidus JB, Tye A. Steric aspects of adrenergic drugs. Journal of Pharmaceutical Sciences 59(9): 1205\u20131234, 1970","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"2","key":"BF03259892_CR159","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0022-3565(25)27031-8","volume":"148","author":"PN Patil","year":"1965","unstructured":"Patil PN, Tye A, Lapidus JB. A pharmacological study of the ephedrine isomers. Journal of Pharmacology and Experimental Therapeutics 148(2): 158\u2013168, 1965","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"14","key":"BF03259892_CR160","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.1984.03350140044023","volume":"252","author":"P Pentel","year":"1984","unstructured":"Pentel P. Toxicity of over-the-counter stimulants. Journal of the American Medical Association 252(14): 1898\u20131903, 1984","journal-title":"Journal of the American Medical Association"},{"key":"BF03259892_CR161","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.1985.03350410037007","volume":"253","author":"P Pentel","year":"1985","unstructured":"Pentel P. Phenylpropanolamine and blood pressure. Journal of the American Medical Association 253: 2492\u20132493, 1985","journal-title":"Journal of the American Medical Association"},{"key":"BF03259892_CR162","first-page":"115","volume":"9","author":"P Pentel","year":"1985","unstructured":"Pentel P, Aaron C, Paya C. Therapeutic doses of phenylpropanolamine increase supine systolic blood pressure. International Journal of Obesity 9: 115\u2013119, 1985a","journal-title":"International Journal of Obesity"},{"issue":"5","key":"BF03259892_CR163","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/clpt.1985.77","volume":"37","author":"P Pentel","year":"1985","unstructured":"Pentel P, Asinger RW, Benowitz NL. Propranolol antagonism of phenylpropanolamine-induced hypertension. Clinical Pharmacology and Therapeutics 37(5): 488\u2013494, 1985b","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259892_CR164","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/clpt.1986.18","volume":"39","author":"P Pentel","year":"1986","unstructured":"Pentel P, Asinger R, Benowitz N. Phenylpropanolamine and blood pressure. Clinical Pharmacology and Therapeutics 39: 102\u2013103, 1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259892_CR165","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0140-6736(82)90358-0","volume":"2","author":"P Pentel","year":"1982","unstructured":"Pentel P, Mikell F. Reaction to phenylpropanolamine\/chlorpheniramine\/belladonna compound in a woman with unrecognised autonomic dysfunction. Lancet 2: 274, 1982","journal-title":"Lancet"},{"key":"BF03259892_CR166","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/hrt.47.1.51","volume":"47","author":"PR Pentel","year":"1982","unstructured":"Pentel PR, Mikell FL, Zavoral JH. Myocardial injury after phenylpropanolamine ingestion. British Heart Journal 47: 51\u201354, 1982","journal-title":"British Heart Journal"},{"issue":"5","key":"BF03259892_CR167","first-page":"650","volume":"28","author":"JG Perkins","year":"1980","unstructured":"Perkins JG, Bressler R, Heatherington D, Cato A, Dickerson J. A bioavailability and safety study comparing Actifed sustained-action (SA) capsules to Actifed immediate-release (IR) tablets. Current Therapeutic Research 28(5): 650\u2013668, 1980","journal-title":"Current Therapeutic Research"},{"key":"BF03259892_CR168","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/0024-3205(80)90496-8","volume":"27","author":"DW Peterson","year":"1980","unstructured":"Peterson DW, Maitai CK, Sparber SB. Relative potencies of two phenylalkylamines found in the abused plant Catha edulis, khat. Life Sciences 27: 2143\u20132147, 1980","journal-title":"Life Sciences"},{"key":"BF03259892_CR169","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jama.1973.03220030058020","volume":"223","author":"RB Peterson","year":"1973","unstructured":"Peterson RB, Vasquez LA. Phenylpropanolamine-induced arrhythmias. Journal of the American Medical Association 223: 324\u2013325, 1973","journal-title":"Journal of the American Medical Association"},{"key":"BF03259892_CR170","first-page":"457","volume-title":"Side effects of drugs annual 7","author":"BCP Polak","year":"1983","unstructured":"Polak BCP. Drugs used in ocular treatment. In Dukes (Ed.) Side effects of drugs annual 7, pp. 457, Excerpta Medica, Amsterdam, 1983"},{"issue":"5","key":"BF03259892_CR171","first-page":"340","volume":"57","author":"M Porta","year":"1986","unstructured":"Porta M, Jick H, Habakangas JAS. Follow-up study of pseudoephedrine users. Annals of Allergy 57(5): 340\u2013342, 1986","journal-title":"Annals of Allergy"},{"key":"BF03259892_CR172","unstructured":"Precup AV (Ed.). Drug Information for the health care provider (USP DI), 6th ed., Vol. 1, The United States Pharmacopeial Convention, Rockville, MD, 1986"},{"issue":"1","key":"BF03259892_CR173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/clpt.1987.100","volume":"42","author":"KS Puder","year":"1987","unstructured":"Puder KS, Morgan JP. Persuading by citation: an analysis of the references of fifty-three published reports of phenylpropanolamine\u2019s clinical toxicity. Clinical Pharmacology and Therapeutics 42(1): 1\u20139, 1987","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"BF03259892_CR174","first-page":"396","volume":"56","author":"K Radack","year":"1986","unstructured":"Radack K, Deck CC. Are oral decongestants safe in hypertension? An evaluation of the evidence and a framework for assessing clinical trials. Annals of Allergy 56(5): 396\u2013401, 1986","journal-title":"Annals of Allergy"},{"key":"BF03259892_CR175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/030006057900700312","volume":"7","author":"U Renvall","year":"1979","unstructured":"Renvall U, Lindqvist N. A double-blind clinical study with Monydrin tablets in patients with non-allergic chronic rhinitis. Journal of International Medical Research 7: 235\u2013239, 1979","journal-title":"Journal of International Medical Research"},{"key":"BF03259892_CR176","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0002-9394(79)90361-1","volume":"87","author":"D Robertson","year":"1979","unstructured":"Robertson D. Contraindication to the use of ocular phenylephrine in idiopathic orthostatic hypotension. American Journal of Ophthalmology 87: 819\u2013822, 1979","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259892_CR177","unstructured":"Roberts RM, Craig S (Eds). Mims, Vol. 20, No. 4, IMS Publishing, New South Wales, June\u2013July, 1983"},{"key":"BF03259892_CR178","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/000348947708600216","volume":"86","author":"RP Roth","year":"1977","unstructured":"Roth RP, Cantekin EI, Bluestone CD, Welch RM, Cho YW. Nasal decongestant activity of pseudoephedrine. Annals of Otology, Rhinology and Laryngology 86: 235\u2013242, 1977","journal-title":"Annals of Otology, Rhinology and Laryngology"},{"key":"BF03259892_CR179","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0196-0644(82)80138-8","volume":"11","author":"BH Rumack","year":"1982","unstructured":"Rumack BH. Phenlypropanolamine: a potentially hazardous drug. Annals of Emergency Medicine 11: 332, 1982","journal-title":"Annals of Emergency Medicine"},{"issue":"6","key":"BF03259892_CR180","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/15563657408988032","volume":"7","author":"BH Rumack","year":"1974","unstructured":"Rumack BH, Anderson RJ, Wolfe R, Fletcher EC, Vestal BK. Ornade and anticholinergic toxicity: hypertension, hallucinations, and arrhythmias. Clinical Toxicology 7(6): 573\u2013581, 1974","journal-title":"Clinical Toxicology"},{"key":"BF03259892_CR181","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archotol.1963.00750010151006","volume":"77","author":"HR Rutstein","year":"1963","unstructured":"Rutstein HR. Ingestion of pseudoephedrine. Archives of Otolaryngology 77: 145\u2013147, 1963","journal-title":"Archives of Otolaryngology"},{"issue":"6","key":"BF03259892_CR182","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0022-3476(79)80316-9","volume":"95","author":"R Saken","year":"1979","unstructured":"Saken R, Kates GL, Miller K. Drug-induced hypertension in infancy. Journal of Pediatrics 95(6): 1077\u20131079, 1979","journal-title":"Journal of Pediatrics"},{"key":"BF03259892_CR183","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/bmj.1.5428.193","volume":"1","author":"PR Salmon","year":"1965","unstructured":"Salmon PR. Hypertensive crisis with Eskornade. British Medical Journal 1: 193, 1965","journal-title":"British Medical Journal"},{"key":"BF03259892_CR184","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/106002808301701012","volume":"17","author":"MB Saltzman","year":"1983","unstructured":"Saltzman MB, Dolan MM, Doyne N. Comparison of effects of two dosage regimens of phenylpropanolamine on blood pressure and plasma levels in normal subjects under steady-state conditions. Drug Intelligence and Clinical Pharmacy 17: 746\u2013750, 1983","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259892_CR185","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(82)92360-1","volume":"1","author":"MB Saltzman","year":"1982","unstructured":"Saltzman MB. Phenylpropanolamine over the counter. Lancet 1: 1242\u20131243, 1982","journal-title":"Lancet"},{"issue":"1","key":"BF03259892_CR186","first-page":"16","volume":"23","author":"S Samantary","year":"1975","unstructured":"Samantary S, Thomas A. Systemic effects of topical phenylephrine. Indian Journal of Ophthalmology 23(1): 16\u201317, 1975","journal-title":"Indian Journal of Ophthalmology"},{"issue":"2","key":"BF03259892_CR187","first-page":"150","volume":"17","author":"A Saunders","year":"1987","unstructured":"Saunders A, Elliott P. Pseudoephedrine in the hypertensive patient. Australian Journal of Hospital Pharmacy 17(2): 150\u2013151, 1987","journal-title":"Australian Journal of Hospital Pharmacy"},{"key":"BF03259892_CR188","first-page":"1363","volume":"280","author":"SR Shapiro","year":"1969","unstructured":"Shapiro SR. Hypertension due to anorectic agent. New England Journal of Medicine 280: 1363, 1969","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"BF03259892_CR189","first-page":"185","volume":"28","author":"HI Silverman","year":"1980","unstructured":"Silverman HI, Kreger BE, Lewis GP, Karabelas A, Paone R, et al. Lack of side effects from orally administered phenylpropanolamine and phenylpropanolamine with caffeine: a controlled three-phase study. Current Therapeutic Research 28(2): 185\u2013194, 1980","journal-title":"Current Therapeutic Research"},{"key":"BF03259892_CR190","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.1982.03320290010007","volume":"247","author":"HI Silverman","year":"1982","unstructured":"Silverman HI, Lewis GP. Phenylpropanolamine. Journal of the American Medical Association 247: 460, 1982","journal-title":"Journal of the American Medical Association"},{"issue":"4","key":"BF03259892_CR191","first-page":"39","volume":"34","author":"HI Silverman","year":"1986","unstructured":"Silverman HI, Shargel L. Phenylpropanolamine. Correspondence. American Family Physician 34(4): 39\u201342, 1986","journal-title":"Correspondence. American Family Physician"},{"key":"BF03259892_CR192","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1042\/bj1360763","volume":"136","author":"JE Sinsheimer","year":"1973","unstructured":"Sinsheimer JE, Dring LG, Williams RT. Species differences in the metabolism of norephedrine in man, rabbit and rat. Biochemical Journal 136: 763\u2013771, 1973","journal-title":"Biochemical Journal"},{"key":"BF03259892_CR193","first-page":"343","volume-title":"Phenylpropanolamine: risks, benefits and controversies","author":"DE Smith","year":"1985","unstructured":"Smith DE. Look-alike drugs and drugs of deception: epidemiological, toxicological, and clinical considerations. In Morgan et al. (Eds) Phenylpropanolamine: risks, benefits and controversies, pp. 343\u2013361, Praeger Publishers, New York, 1985"},{"key":"BF03259892_CR194","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0196-0644(82)80067-X","volume":"11","author":"S Smookler","year":"1982","unstructured":"Smookler S, Bermudez AJ. Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant. Annals of Emergency Medicine 11: 482\u2013484, 1982","journal-title":"Annals of Emergency Medicine"},{"issue":"2","key":"BF03259892_CR195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00000542-197202000-00026","volume":"36","author":"D Solosko","year":"1972","unstructured":"Solosko D, Smith RB. Hypertension following 10 per cent phenylephrine ophthalmic. Anesthesiology 36(2): 187\u2013189, 1972","journal-title":"Anesthesiology"},{"issue":"4","key":"BF03259892_CR196","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.STR.16.4.734","volume":"16","author":"AJ Stoessl","year":"1985","unstructured":"Stoessl AJ, Young GB, Feasby TE. Intracerebral haemorrhage and angiographic beading following ingestion of catecholaminergics. Stroke 16(4): 734\u2013736, 1985","journal-title":"Stroke"},{"issue":"IV","key":"BF03259892_CR197","first-page":"33","volume":"26","author":"RN Sud","year":"1979","unstructured":"Sud RN, Grewal SS. Phenylephrine \u2014 systemic effects from its topical use. Indian Journal of Ophthalmology 26(IV): 33\u201337, 1979","journal-title":"Indian Journal of Ophthalmology"},{"key":"BF03259892_CR198","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/00000441-193306000-00013","volume":"185","author":"ML Tainter","year":"1933","unstructured":"Tainter ML, Stockton AB. Comparative actions of sympatho mimetic compounds: the circulatory and local actions of the optical isomers of meta-synephrine and possible therapeutic applications. American Journal of Medical Sciences 185: 832\u2013843, 1933","journal-title":"American Journal of Medical Sciences"},{"issue":"2","key":"BF03259892_CR199","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1378\/chest.68.2.155","volume":"68","author":"DP Tashkin","year":"1975","unstructured":"Tashkin DP, Meth R, Simmons DH, Lee YE. Double-blind comparison of acute bronchial and cardiovascular effects of oral terbutaline and ephedrine. Chest 68(2): 155\u2013161, 1975","journal-title":"Chest"},{"key":"BF03259892_CR200","first-page":"425","volume":"60","author":"AYF Teh","year":"1979","unstructured":"Teh AYF. Phenylpropanolamine and hypertension. Medical Journal of Australia 60: 425\u2013426, 1979","journal-title":"Medical Journal of Australia"},{"key":"BF03259892_CR201","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bmj.1.5434.589-b","volume":"1","author":"CM Tonks","year":"1965","unstructured":"Tonks CM, Lloyd AT. Hazards with monoamine-oxidase inhibitors. British Medical Journal 1: 589, 1965","journal-title":"British Medical Journal"},{"key":"BF03259892_CR202","volume-title":"Chemical aspects of the autonomic nervous system","author":"DJ Triggle","year":"1965","unstructured":"Triggle DJ. Chemical aspects of the autonomic nervous system, Academic Press, New York, 1965"},{"key":"BF03259892_CR203","first-page":"260","volume":"25","author":"DL Unger","year":"1967","unstructured":"Unger DL, Unger L, Temple DE. Effect of an antiasthmatic compound on blood pressure of hypertensive asthmatic patients. Annals of Allergy 25: 260\u2013261, 1967","journal-title":"Annals of Allergy"},{"key":"BF03259892_CR204","first-page":"637","volume":"26","author":"DL Unger","year":"1968","unstructured":"Unger DL. Blood pressure and pulse rate changes in hypertensive asthmatic patients: effects of an ephedrine compound. Annals of Allergy 26: 637\u2013638, 1968","journal-title":"Annals of Allergy"},{"key":"BF03259892_CR205","first-page":"476","volume":"31","author":"OE Alyea Van","year":"1952","unstructured":"Van Alyea OE, Donnelly WA. Systemic effects of intransal medication. Eye, Ear, Nose and Throat Monthly 31: 476\u2013480, 1952","journal-title":"Eye, Ear, Nose and Throat Monthly"},{"key":"BF03259892_CR206","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2165\/00003495-197816040-00004","volume":"16","author":"RE Vestal","year":"1978","unstructured":"Vestal RE. Drug use in the elderly: a review of problems and special considerations. Drugs 16: 358\u2013382, 1978","journal-title":"Drugs"},{"key":"BF03259892_CR207","volume-title":"Martindale: the extra pharmacopoeia","year":"1982","unstructured":"Wade A (Ed.). Martindale: the extra pharmacopoeia, 28th ed., The Pharmaceutical Press, London, 1982","edition":"28th"},{"key":"BF03259892_CR208","first-page":"145","volume-title":"Goodman and Oilman\u2019s pharmacological basis of therapeutics","author":"N Weiner","year":"1985","unstructured":"Weiner N. Norepinephrine, epinephrine, and the sympathomimctic amines. In Oilman et al. (Eds) Goodman and Oilman\u2019s pharmacological basis of therapeutics, pp. 145\u2013179, MacMillan Publishing Co., New York, 1985a"},{"key":"BF03259892_CR209","first-page":"181","volume-title":"Goodman and Oilman\u2019s pharmacological basis of therapeutics","author":"N Weiner","year":"1985","unstructured":"Weiner N. Drugs that inhibit adrenergic nerves and block adrenergic receptors. In Oilman et al. (Eds) Goodman and Oilman\u2019s pharmacological basis of therapeutics, pp. 181\u2013211, MacMillan Publishing Co., New York, 1985b"},{"issue":"3","key":"BF03259892_CR210","first-page":"183","volume":"31","author":"WB White","year":"1985","unstructured":"White WB, Riotte K. Drugs for cough and cold symptoms in hypertensive patients. American Family Physician 31(3): 183\u2013187, 1985","journal-title":"American Family Physician"},{"issue":"1","key":"BF03259892_CR211","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0002-9394(73)90023-8","volume":"76","author":"JT Wilensky","year":"1973","unstructured":"Wilensky JT, Woodward HJ. Acute systemic hypertension after conjunctival instillation of phenylephrine hydrochloride. American Journal of Ophthalmology 76(1): 156\u2013157, 1973","journal-title":"American Journal of Ophthalmology"},{"issue":"9","key":"BF03259892_CR212","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/jps.2600690924","volume":"69","author":"A Yacobi","year":"1980","unstructured":"Yacobi A, Stoll RG, Chao GC, Carter JE, Baaske DM, et al. Evaluation of sustained-action chlorpheniramine-pseudoephedrine dosage form in humans. Journal of Pharmaceutical Sciences 69(9): 1077\u20131081, 1980","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"BF03259892_CR213","first-page":"40","volume":"17","author":"CW Zumpft","year":"1975","unstructured":"Zumpft CW. Double-blind comparison of metizoline hydrochloride (ELLSYL) and phenylephrine in allergic and vasomotor rhinitis. Current Therapeutic Research 17(1): 40\u201346, 1975","journal-title":"Current Therapeutic Research"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259892\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T23:05:06Z","timestamp":1745363106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,10]]},"references-count":213,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1988,10]]}},"alternative-id":["BF03259892"],"URL":"https:\/\/doi.org\/10.1007\/bf03259892","relation":{},"ISSN":["0112-5966"],"issn-type":[{"value":"0112-5966","type":"print"}],"subject":[],"published":{"date-parts":[[1988,10]]}}}